Table 1:
Characteristic | High AUC n=46 | Low AUC n=131 | p-value |
---|---|---|---|
Mean age, yrs | 56.8 | 61.9 | 0.0157 |
Gender | |||
Male | 33 (72%) | 66 (50%) | 0.0154 |
Female | 13 (28%) | 65 (50%) | |
Resection | |||
Wedge or segment | 21 (46%) | 56 (43%) | 0.8854 |
Lobectomy | 16 (20%) | 45 (34%) | |
Trisectionectomy | 9 (34%) | 30 (23%) | |
Extra-hepatic disease | |||
Yes | 5 (11%) | 17 (13%) | 0.2019 |
No | 41 (89%) | 114 (87%) | |
Prior liver resection | |||
Yes | 3 (7%) | 9 (7%) | 1.000 |
No | 43 (94%) | 122 (93%) | |
Preoperative chemotherapy | |||
Yes | 33 (79%) | 82 (63%) | 0.2867 |
No | 13 (21%) | 49 (37%) | |
Mean preop CEA (95% CI) | 134.9 (−146–416) | 127.6 (−19–274) | 0.9629 |
Mean largest tumor diameter, cm (95% CI) | 4.3 (4.2–5.3) | 4.8 (3.4–5.2) | 0.4201 |
Tumor number | |||
1 | 28 (60%) | 65 (50%) | 0.2276 |
2 | 5 (11%) | 29 (22%) | |
3 | 5 (11%) | 19 (15%) | |
4 | 3 (7%) | 8 (6%) | |
5 | 0 (0%) | 3 (2%) | |
>5 | 5(11%) | 7 (5%) | |
Disease free interval, mos (95% CI) | 16.0 (10.8–21.1) | 18.4 (15.4–21.5) | 0.4188 |
Clinical risk score | |||
1 | 20 (43%) | 42 (32%) | 0.9033 |
2 | 16 (35%) | 54 (41%) | |
3 | 7 (15%) | 20 (15%) | |
4 | 3 (7%) | 14 (11%) | |
5 | 0 (0%) | 1 (1%) |